19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
In Edwards v. Arthur Andersen LLP, 44 Cal. 4th 937 (2008), the California Supreme Court held that co...
Read More >
The Iowa Democratic Presidential Caucus historically signals who the likely Democratic Presidential ...
Read More >
Workers Found Scrawled Racial Slurs and Noose at Apple Park Construction Site, Federal Agency Charge...
Read More >
In Part 1 of this series of posts, we discussed how business owners must think beyond the near term ...
Read More >
On April 23, Kramer Levin reported on the European Parliament’s approved proposal for the adoption ...
Read More >
The New York Senate and Assembly recently passed Senate Bill S2844B to strengthen current laws for e...
Read More >